The largest database of trusted experimental protocols

Multiscreen hts ip plate

Manufactured by Merck Group
Sourced in Germany

The Multiscreen HTS-IP plate is a high-throughput screening (HTS) filter plate designed for in-vitro protein-protein interaction (IP) studies. The plate provides a platform for rapid filtration and washing of samples during the IP process, enabling efficient capture and separation of target proteins and associated complexes.

Automatically generated - may contain errors

7 protocols using multiscreen hts ip plate

1

Quantifying IFNγ and IL-13 Secreting Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ELISPOT assays, MoDC/T cell or MoDC/PBMC co-cultures were performed in 96-well MultiScreen HTS IP plates (0.45 μm, clear, Merck Chemicals GmbH, Darmstadt, Germany), coated with anti-IFNγ capture antibody (BD Biosciences, Heidelberg, Germany) overnight at 4°C. Following blocking for two hours at room temperature with culture medium, cells were seeded and stimulated as described above. After 16 h incubation, cells were discarded and plates washed in sterile water and PBS / 0.05% Tween20 (Sigma-Aldrich Chemie GmbH, Munich, Germany). Biotinylated anti-human IFNγ detection antibody (BD Biosciences, Heidelberg, Germany) was added in PBS / 10% FCS and plates incubated for two hours. After washing in PBS / 0.05% Tween20 Alkaline Phosphatase (AP)-conjugated Streptavidin (BD Biosciences, Heidelberg, Germany) was added 1:1000 in PBS/10% FCS followed by incubation for one hour. Development of the plate was performed with the AP conjugate substrate kit (Bio-Rad Laboratories GmbH, München, Germany); the reaction was stopped with water and the plate dried overnight.
FluoroSpot assay was carried out using the MabTech Kit (IFNγ/IL-13, MabTech, Stockholm, Sweden) following the provided protocol.
Spots and enzymatic activity were quantified with an iSpot FluoroSpot Reader System (AID, Strassberg, Germany).
+ Open protocol
+ Expand
2

Peptide-Specific IFN-γ Release Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptide-specific release of IFN-ɤ was assessed as previously described (9 (link)). Briefly, 96 Well MultiScreenHTS IP plates (0.45 mm, Merck Millipore, Darmstadt, Germany) were coated over night at 4°C with murine anti-IFN-ɤ antibody (clone AN18, Mabtech, Nacka Strand, Sweden (10 μg/ml)). After a washing step with PBS, the membrane was blocked with IMDM (Gibco, Carlsbad, USA) supplemented with 10% FCS, 1% glutamine and 1% sodium pyruvate for at least 60 min at 37°C. Spleen single cell suspensions were prepared as described before. 5x105 splenocytes were incubated in the absence or presence of OVA257-264 or OVA323-337 peptides (each 1 μM). After 20 h of incubation at 37° C and 5% CO2 the plate was washed six times with PBS including 0.05% Tween and the produced IFN-ɤ was detected with a biotinylated anti-IFN-ɤ antibody (clone R4-6A2, Mabtech, Nacka Strand, Sweden (2μg/ml)). After an additional washing step as described above, the enzyme-substrate reaction was performed to visualize the occurred binding using the Vectastain ABC Kit (Vector Laboratories, Burlingame, USA) together with AEC (Sigma-Aldrich, Taufkirchen, Germany) as described by the manufacturer. The reaction was stopped with H2O. After drying, spot forming units (SFU) were measured with the automated image analysis system AID iSpot ELISpot reader (AID Autoimmun Diagnostika, Straßberg, Germany).
+ Open protocol
+ Expand
3

Measurement of Tumor-Specific Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumour-specific immune responses to IFN-γ were measured in vitro by ELISpot assay (Mouse IFN-γ ELISPOT Ready-SET-Go!; Cat. No. 88–7384-88; eBioscience). A Millipore Multiscreen HTS-IP plate was coated overnight at 4 °C with anti-mouse IFN-γ capture antibody. TRAMP-C2 cells were irradiated with X-ray irradiator at a dose of 100 Gy to expose tumour-specific antigen. Single-cell suspensions of splenocytes were obtained from TRAMP-C2 tumour-carrying mice and seeded onto the antibody-coated plate at a concentration of 2×105 cells per well. Cells were incubated with or without antigen-exposed TRAMP-C2 cells for 42 h at 37 °C and then discarded. The plate was then incubated with biotin-conjugated anti-IFN-γ detection antibody at r.t. for 2 h, followed by incubation with Avidin-HRP at r.t. for 2 h. 3-amino-9-ethylcarbazole substrate solution (Cat. AEC101, Sigma, USA) was added for cytokine spot detection. Spots were imaged and quantified with a CTL ImmunoSpot Analyser (Cellular Technology Ltd, USA).
+ Open protocol
+ Expand
4

Tumor-specific IFN-γ ELISPOT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISPOT assay (Mouse IFN-γ ELISPOT Ready-SET-Go!®; Cat. No. 88-7384-88; eBioscience) was performed to determine tumor-specific immune responses to IFN-γ in vitro. A Millipore Multiscreen HTS-IP plate was coated with anti-Mouse IFN-γ capture antibodies overnight at 4 °C. Single-cell suspensions of splenocytes obtained from MC38 tumor-bearing mice 12 days after the first treatment were seeded onto the antibody-coated plate at a concentration of 2 × 105 cells/well, incubated with or without KSPWFTTL (10 mg/ml; PEPTIDE 2.0) for 48 h at 37°C. Biotin-conjugated anti-IFN-γ detection antibody was then added into the plate and incubated at room temperature for 2 h, followed by Avidin-HRP incubation for another 2 h at room temperature. After addition of 3-amino-9-ethylcarbazole (AEC) substrate solution (Sigma, Cat. AEC101), IFN-γ spots were detected by ELISpot reader.
+ Open protocol
+ Expand
5

Tumor-Specific IFN-γ ELISPOT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-specific immune responses to IFN-γ were measured in vitro by ELISPOT assay (Mouse IFN-γ ELISPOT Ready-SET-Go!; Cat. No. 88-7384-88; eBioscience). 4T1 cells were irradiated with X-ray irradiator at a dose of 50 Gy to expose tumor-specific antigen. A Millipore Multiscreen HTS-IP plate was coated overnight at 4 °C with anti-mouse IFN-γ capture antibody. Single-cell suspensions of splenocytes were obtained from 4T1 tumorcarrying mice and seeded onto the antibody-coated plate at a concentration of 2×105 cells per well. Cells were incubated with or without SVYDFFVWL stimulation (10 mg/ml; in purity >95%; Genscript, USA) for 42 h at 37 °C and then discarded. The plate was then incubated with biotin-conjugated anti-IFN-γ detection antibody at r.t. for 2 h, followed by incubation with Avidin-HRP at r.t. for 2 h. 3-amino-9-ethylcarbazole substrate solution (Sigma, Cat. AEC101) was added for cytokine spot detection. Spots were imaged and quantified with a CTL ImmunoSpot Analyzer (Cellular Technology Ltd, USA).
+ Open protocol
+ Expand
6

Quantifying Tumor-Specific IFN-γ Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumour-specific immune responses to IFN-γ was measured in vitro by an ELISPOT assay (Mouse IFN-γ ELISPOT Ready-SET-Go!®; Cat. No. 88-7384-88; eBioscience). A Millipore Multiscreen HTS-IP plate was coated overnight at 4 °C with anti-Mouse IFN-γ capture antibody (diluted 1:250). Single-cell suspensions of splenocytes were obtained from MC38 tumour-carrying mice on 12 days after the first treatment and seeded onto the antibody-coated plate at a concentration of 2 × 105 cells/well. Cells were incubated with or without KSPWFTTL stimulation (10 µg/mL; in purity 495%; PEPTIDE 2.0) for 48 h at 37 °C and then discarded. The plate was then incubated with biotin-conjugated anti-IFN-γ detection antibody (diluted 1:250) at room temperature for 2 h, followed by incubation with Avidin-HRP for 2 h at room temperature. 3-amino-9-ethylcarbazole (AEC) substrate solution (Sigma, Cat. AEC101) was added for cytokine spot detection.
+ Open protocol
+ Expand
7

Tumor-specific IFN-γ ELISPOT assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-specific immune responses to IFN-γ were measured in vitro by ELISPOT assay (Mouse IFN-γ ELISPOT Ready-SET-Go!; Cat. No. 88-7384-88; eBioscience). 4T1 cells were irradiated with X-ray irradiator at a dose of 50 Gy to expose tumor-specific antigen. A Millipore Multiscreen HTS-IP plate was coated overnight at 4 °C with anti-mouse IFN-γ capture antibody. Single-cell suspensions of splenocytes were obtained from 4T1 tumor-carrying mice and seeded onto the antibody-coated plate at a concentration of 2×105 cells per well. Cells were incubated with or without antigen-exposed 4T1 cell stimulation (1×104 cells per well) for 42 h at 37 °C and then discarded. The plate was then incubated with biotin-conjugated anti-IFN-γ detection antibody at r.t. for 2 h, followed by incubation with Avidin-HRP at r.t. for 2 h. 3-amino-9-ethylcarbazole substrate solution (Sigma, Cat. AEC101) was added for cytokine spot detection. Spots were imaged and quantified with a CTL ImmunoSpot Analyzer (Cellular Technology Ltd, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!